SGA Prescribing Higher for Veterans With PTSD/Dementia

This article originally appeared here.
Share this content:
SGA Prescribing Higher for Veterans With PTSD/Dementia
SGA Prescribing Higher for Veterans With PTSD/Dementia

FRIDAY, April 7, 2017 (HealthDay News) -- Elderly veterans with post-traumatic stress disorder (PTSD) with dementia have increased odds of being prescribed second-generation antipsychotics (SGAs) compared with those with PTSD alone, according to a study published online April 3 in the Journal of the American Geriatrics Society.

Todd P. Semla, Pharm.D., from the Department of Veterans Affairs in Hines, Ill., and colleagues conducted a national cross-sectional study involving 93,068 veterans aged 65 years and older with PTSD with or without concomitant dementia (11.1 percent with dementia). They examined trends in SGA prescribing in the population.

The researchers found that there was an annual decrease in SGA prescribing between 2004 and 2009, from 7 to 5.1 percent of elderly veterans with PTSD without dementia and from 13.2 to 8.9 percent in those with dementia. Over time, the findings consistently showed that veterans with PTSD and dementia versus those without dementia had at least twice the odds of being prescribed an SGA (odds ratios, 2.03 to 2.33).

"The findings were consistent over six years and strongly suggest that providers need to be educated about the complexities of prescribing SGAs to individuals with multiple medical and mental comorbidities," the authors write. "Future work should consider dissemination strategies to better understand why providers practice in this way."

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Actemra to Treat Giant Cell Arteritis

FDA Approves Actemra to Treat Giant Cell Arteritis

New indication provides the first FDA-approved therapy specific to this type of vasculitis

Trends in Teen Binge Drinking Still Raise Concerns

Trends in Teen Binge Drinking Still Raise Concerns

Even though frequent binge drinking among adolescents has dropped in past 25 years

ATS: First Abx Rx Doesn't Work for 25 of Pneumonia Cases

ATS: First Abx Rx Doesn't Work for ~25% ...

One in four adult patients do not respond to initial prescription of antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »